Home > Publications > Medical Specialty > Internal Medicine > Haematology > Thrombosis and Haemostasis > Thrombosis & Haemostasis Research Review, Issue 35
Thrombosis & Haemostasis Research Review, Issue 35

Thrombosis & Haemostasis Research Review, Issue 35

In this issue:

Fibrin identified as driving coagulopathy and inflammation in COVID
Elevated risk of stroke in AF patients with positive aPL antibodies
PCC reverses factor Xa inhibitor anticoagulation prior to emergency surgery
Emicizumab prophylaxis bests immediate IST in AHA
Hypoalbuminemia linked to risk of thrombotic events
Patients with low-risk AF at risk for vascular dementia
PATH-HHT: pomalidomide efficacious for HHT
Promising efficacy for anti-CD38 antibody in recurrent and refractory ITP
Risk of recurrent VTE with hormonal contraception
Outcomes in patients receiving preoperative low-dose rivaroxaban and/or aspirin

You need to be logged in to access this content.

Harshal-Nandurkar

Expert contributor

Professor Harshal Nandurkar

Prof Harshal Nandurkar is Head of the Australian Centre for Blood Diseases and Director of Clinical Haematology at Alfred Health. He is current Vice President of the Australasian Society of Thrombosis and Haemostasis.

Latest Publications and Videos

Stay up to date with our latest clinical information.

Explore Research Review Publications and Videos

Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry. 

Find Reviews in Your Clinical Area
Please select your country of practice.

It looks like you are closest to our New Zealand site.

Terms and Conditions

Website terms of use 

By using our website, you agree to follow these terms and conditions. 

 

Privacy policy 

We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms. 

 

Copyright and use of website content 

The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use. 

You cannot:  copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission. 

 

Links to third-party websites 

The Research Review website may link to third-party websites for your convenience. However: 

We do not endorse or approve their products, services, or actions. 

We are not responsible for their content or how they operate. 

There is no formal partnership between us and third parties unless we clearly state otherwise. 

 

Disclaimer and limitation of liability 

We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date. 

To the fullest extent allowed by law, we are not responsible for: 

Any loss, damage, or costs you may suffer from using (or being unable to use) our website. 

Any decisions you make based on the information provided. 

Any business losses, such as lost profits, lost data, or business interruptions. 

 

Governing law 

These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.